SCHEMBL14264702

SCHEMBL14264702

CN/N=C(\Cl)c1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 3/20 0.41
TDP1 Q9NUW8 2/20 0.41
NPSR1 Q6W5P4 1/20 0.41
MAPT P10636 3/20 0.41
POLB P06746 1/20 0.41
ALDH1A1 P00352 7/20 0.39
KDM4E B2RXH2 3/20 0.38
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
LMNA P02545 3/20 0.38
RAB9A P51151 2/20 0.38
ATM Q13315 2/20 0.38
NPC1 O15118 1/20 0.38
GLA P06280 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
METTL3 Q86U44 1/20 0.38
TSHR P16473 2/20 0.38
SMN1; SMN2 Q16637 3/20 0.37
HIF1A Q16665 1/20 0.36
NFKB1 P19838 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL962604 0.78 ALDH1A1 (0.48) GAATDP1NPSR1MAPTPOLB
SCHEMBL960636 0.76 MAPT (0.61) GAATDP1NPSR1MAPTPOLB
SCHEMBL960634 0.76 MAPT (0.61) GAATDP1NPSR1MAPTPOLB
SCHEMBL7456390 0.75 ATM (0.39) TDP1MAPTPOLBALDH1A1MEN1
SCHEMBL7487833 0.75 ATM (0.39) TDP1MAPTPOLBALDH1A1MEN1
SCHEMBL8138377 0.74 GAA (0.47) GAATDP1NPSR1MAPTALDH1A1
SCHEMBL8138375 0.74 GAA (0.47) GAATDP1NPSR1MAPTALDH1A1
SCHEMBL12997974 0.74 ATM (0.41) GAATDP1NPSR1MAPTPOLB
SCHEMBL4487426 0.74 MEN1 (0.50) GAATDP1NPSR1MAPTPOLB
SCHEMBL8269193 0.74 CA12 (0.41) GAATDP1NPSR1MAPTPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10790451-B2 Triazole derivative, and light-emitting element, light-emitting device, and electronic device with the use of triazole derivative SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2020-09-29 US disclosed
US-20080070869-A1 Malonyl-CoA Decarboxylase Inhibitors Useful as Metabolic Modulators CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2008-03-20 US disclosed
US-7279477-B2 Malonyl-CoA decarboxylase inhibitors useful as metabolic modulators CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2007-10-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080070869-A1 Malonyl-CoA Decarboxylase Inhibitors Useful as Metabolic Modulators MLYCD, ME3, ACACA GAA 67/4885TDP1 1659/4885NPSR1 4820/4885
US-10790451-B2 Triazole derivative, and light-emitting element, light-emitting device, and electronic device with the use of triazole derivative TYR, TH, YEATS4 GAA 2682/4885TDP1 2738/4885NPSR1 3943/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.